Legal & General Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.06M Sell
669,375
-8,668
-1% -$104K ﹤0.01% 1230
2026
Q1
$4.06M Sell
678,043
-101,725
-13% -$765K ﹤0.01% 1607
2025
Q4
$5.59M Sell
779,768
-32,072
-4% -$253K ﹤0.01% 1500
2025
Q3
$8.67M Sell
811,840
-24,391
-3% -$239K ﹤0.01% 1282
2025
Q2
$8.09M Buy
836,231
+42,836
+5% +$442K ﹤0.01% 1305
2025
Q1
$11.8M Sell
793,395
-5,522
-0.7% -$84.9K ﹤0.01% 1053
2024
Q4
$11.9M Buy
798,917
+3,219
+0.4% +$52.5K ﹤0.01% 1087
2024
Q3
$15.2M Buy
795,698
+7,440
+0.9% +$154K ﹤0.01% 953
2024
Q2
$16.3M Sell
788,258
-6,330
-0.8% -$126K ﹤0.01% 904
2024
Q1
$14.9M Sell
794,588
-6,294
-0.8% -$108K ﹤0.01% 946
2023
Q4
$11.5M Buy
800,882
+202,154
+34% +$2.75M ﹤0.01% 1050
2023
Q3
$10.4M Sell
598,728
-789,735
-57% -$16.5M ﹤0.01% 1051
2023
Q2
$28.9M Sell
1,388,463
-32,554
-2% -$708K 0.01% 734
2023
Q1
$33.4M Sell
1,421,017
-52,945
-4% -$1.42M 0.01% 701
2022
Q4
$41.2M Sell
1,473,962
-123,221
-8% -$3.15M 0.02% 663
2022
Q3
$37.4M Sell
1,597,183
-216,928
-12% -$6.55M 0.01% 678
2022
Q2
$61.2M Buy
1,814,111
+49,205
+3% +$1.72M 0.02% 596
2022
Q1
$61.6M Buy
1,764,906
+403,473
+30% +$13.8M 0.02% 628
2021
Q4
$41.5M Buy
1,361,433
+20,321
+2% +$662K 0.01% 713
2021
Q3
$44M Buy
1,341,112
+1,338,800
+57,907% +$42.8M 0.01% 701
2021
Q2
$70K Buy
+2,312
New +$76.1K ﹤0.01% 2847

Other funds holding OGN

Legal & General Group's OGN Position: Q2 2026 in Review

Legal & General Group reduced its Organon & Co (OGN) stake by 1.3% in Q2 2026, selling an estimated $104K and leaving 669,375 shares worth $9.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1230.

Legal & General Group first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $61.6M in Q1 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Legal & General Group held 669,375 shares of Organon & Co worth $9.06M as of Q2 2026.
  • Legal & General Group sold 8,668 Organon & Co shares in Q2 2026, an estimated $104K.
  • Organon & Co made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1230 holding.
  • Legal & General Group first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Legal & General Group's Organon & Co position peaked at $61.6M in Q1 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.